These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18223205)

  • 1. Is breast tumor progression really linear?
    Polyak K
    Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
    Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T
    Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.
    Ivkovic-Kapicl T; Knezevic-Usaj S; Djilas-Ivanovic D; Panjkovic M
    In Vivo; 2007; 21(4):673-8. PubMed ID: 17708365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of intraductal carcinoma with pleomorphic cells.
    Cordoba A; Guerrero-Setas D; Vicente F; Mercado MR; Rodriguez I; Martinez-Peñuela JM
    Pathol Int; 2012 Jul; 62(7):511-2. PubMed ID: 22726073
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
    García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
    Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cytokeratin expression in relation to biological factors in breast cancer.
    Kuroda H; Ishida F; Nakai M; Ohnisi K; Itoyama S
    Hum Pathol; 2008 Dec; 39(12):1744-50. PubMed ID: 18755493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
    Simooka H; Oyama T; Sano T; Horiguchi J; Nakajima T
    Pathol Int; 2004 Aug; 54(8):595-602. PubMed ID: 15260850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
    Kaya H; Bozkurt SU; Erbarut I; Djamgoz MB
    Pathol Res Pract; 2008; 204(6):367-71. PubMed ID: 18342452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
    Yoder BJ; Wilkinson EJ; Massoll NA
    Breast J; 2007; 13(2):172-9. PubMed ID: 17319859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of breast lesions with proton MR spectroscopy.
    Yeh ED
    AJR Am J Roentgenol; 2003 Nov; 181(5):1273-4. PubMed ID: 14573419
    [No Abstract]   [Full Text] [Related]  

  • 16. Expressions of cyclin D1, p53, bcl-2, and bax in infiltrative ductal carcinoma of the breast: correlations with clinicopathologic characteristics.
    Arýkök AT; Onal BU; Han U
    Breast J; 2006; 12(4):391-2. PubMed ID: 16848860
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma.
    Kim DJ; Park JY; Lee MH; Sohn YK
    J Korean Med Sci; 2004 Oct; 19(5):698-703. PubMed ID: 15483347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of HER2 protein examination in ductal carcinoma in situ.
    Horimoto Y; Tokuda E; Arakawa A; Kosaka T; Saito M; Kasumi F
    J Surg Res; 2011 May; 167(2):e205-10. PubMed ID: 20018297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
    Faratian D; Munro A; Twelves C; Bartlett JM
    Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations.
    Formantici C; Orlandi R; Ronchini C; Pilotti S; Ranzani GN; Colnaghi MI; Ménard S
    J Pathol; 1999 Mar; 187(4):424-7. PubMed ID: 10398101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.